Palisade Bio (PALI) Total Non-Current Liabilities (2011 - 2026)
Palisade Bio's Total Non-Current Liabilities came in at $5.31 million for Q2 2026, up 33.6% from $3.97 million a year earlier but down 6.6% from the prior quarter.
Powered by 
Analysis
Palisade Bio (PALI) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
At the end of FY2025, Palisade Bio's Total Non-Current Liabilities was $4.7 million, up 45.1% from FY2024.
- Total Non-Current Liabilities carries a five-year compound annual growth rate of -23.4% (FY2020 to FY2025).
- Going back by year, Total Non-Current Liabilities was $3.24 million in FY2024 (+20.9%), $2.68 million in FY2023 (-16.9%), $3.22 million in FY2022 (+29.1%) and $2.5 million in FY2021 (-86.0%).
- The five-year range for quarterly Total Non-Current Liabilities is $1.5 million (Q1 2023) to $5.68 million (Q1 2026).
- Year-over-year, Total Non-Current Liabilities has increased for seven consecutive quarters, with growth averaging 34.9% over the last eight quarters.
- The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q1 2026 (growth of 104.5%), and the weakest in Q1 2022 (a decline of 93.5%).
- Business Quant data shows PALI's Total Non-Current Liabilities at $5.68 million (Q1 2026), $4.7 million (Q4 2025) and $3.48 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Palisade Bio | 251.71 Mn | -144.73 Mn | - | 5.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.31 Mn |
| Mar 31, 2026 | 5.68 Mn |
| Dec 31, 2025 | 4.70 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Jun 30, 2025 | 3.97 Mn |
| Mar 31, 2025 | 2.78 Mn |
| Dec 31, 2024 | 3.24 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 2.86 Mn |
| Mar 31, 2024 | 2.53 Mn |
| Dec 31, 2023 | 2.68 Mn |
| Sep 30, 2023 | 2.77 Mn |
| Jun 30, 2023 | 2.49 Mn |
| Mar 31, 2023 | 1.50 Mn |
| Dec 31, 2022 | 3.22 Mn |
| Sep 30, 2022 | 3.75 Mn |
| Jun 30, 2022 | 3.13 Mn |
| Mar 31, 2022 | 1.86 Mn |
| Dec 31, 2021 | 2.50 Mn |
| Sep 30, 2021 | 2.92 Mn |
API Access
Palisade Bio Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PALI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "PALI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PALI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();